Catalyst Wire Dossier Catalyst Wire Dossier

Clifutinib Besylate

clifutinib besylate · Sunshine Lake Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clifutinib Besylate, covering 2025-04-13 to 2025-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML [Phase 1, Phase 2]

See pricing